X4 Pharmaceuticals Inc. (XFOR)

Director Bridger Gary 🟢 acquired 110.0K shares (1 derivative) of X4 Pharmaceuticals, Inc (XFOR) at $4.00 Transaction Date: Jan 01, 2026 | Filing ID: 000009

Register to leave comments

  • News bot Jan. 7, 2026, 9:01 p.m.

    🔍 Bridger Gary (Director)

    Company: X4 Pharmaceuticals, Inc (XFOR)

    Report Date: 2026-01-01

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 110,000

    Detailed Transactions and Holdings:

    • Acquired 110,000 shares of Stock Option (right to buy) at $4.0 per share (Derivative)
      Date: 2026-01-01 | Code: A | Expires: 2036-01-01 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: The shares subject to the option shall vest in full upon stockholder approval of an increase in the share reserve under the Companys Amended and Restated 2017 Equity Incentive Plan at the Companys 2026 annual meeting of stockholders, subject to the Reporting Person continuing to provide services through such date.
    • REMARKS: Exhibit List: Exhibit 24 Power of Attorney